Skip to main content

Mahon Paul A

EVP &General Counsel | EVP &General Counsel

1 company

Insider Signal Score

46
Average
Trades Analyzed
84
12M Win Rate
15.7%
Avg 3M Return
-7.5%
Avg 12M Return
-29.9%

Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 35 sells.

Estimated insider holdings value: $19.5M based on current market prices.

Holdings by Company

UTHRMar 5, 2026
Current Shares36.8K
Value$19.47M
Net Activity-599,952
Bought: 0Sold: 600.0K

Transaction History

Showing 10 filings (page 3)
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Apr 3, 2025
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE11,000$306.18$3,367,983.80-4.1%-3.9%+85.5%
Dec 5, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE7,700$374.37$2,882,649.00-17.3%-16.9%+30.7%
Nov 21, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE7,700$367.36$2,828,672.00-17.3%+3.7%+29.3%
Apr 4, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$232.37$1,394,248.25-3.0%+33.0%+25.0%
Mar 21, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$236.45$1,418,726.00-3.7%+30.4%+32.1%
Mar 7, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$237.38$1,424,309.07-5.0%+15.3%+31.7%
Feb 15, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$215.31$1,291,884.86-4.9%+27.1%+72.7%
Feb 1, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$215.01$1,290,083.29-3.7%+18.1%+62.6%
Jan 18, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$218.72$1,312,322.33-3.1%+7.4%+63.8%
Jan 4, 2024
UTHR
United Therapeutics Corp
EVP &General CounselSale+OE6,000$227.97$1,367,798.18-5.0%+0.5%+54.9%